Essex Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,159
Closed -$954K 364
2023
Q3
$954K Sell
1,159
-212
-15% -$174K 0.16% 208
2023
Q2
$985K Sell
1,371
-595
-30% -$428K 0.14% 209
2023
Q1
$1.62M Sell
1,966
-139
-7% -$114K 0.23% 136
2022
Q4
$1.52M Sell
2,105
-4,115
-66% -$2.97M 0.24% 129
2022
Q3
$4.29M Sell
6,220
-386
-6% -$266K 0.68% 36
2022
Q2
$3.91M Sell
6,606
-285
-4% -$168K 0.63% 45
2022
Q1
$4.81M Buy
6,891
+447
+7% +$312K 0.6% 48
2021
Q4
$4.07M Hold
6,444
0.47% 56
2021
Q3
$3.9M Buy
6,444
+21
+0.3% +$12.7K 0.48% 57
2021
Q2
$3.59M Sell
6,423
-421
-6% -$235K 0.42% 73
2021
Q1
$3.24M Sell
6,844
-432
-6% -$204K 0.39% 76
2020
Q4
$3.52M Sell
7,276
-222
-3% -$107K 0.44% 70
2020
Q3
$4.2M Sell
7,498
-79
-1% -$44.2K 0.6% 29
2020
Q2
$4.73M Sell
7,577
-6,647
-47% -$4.15M 0.77% 22
2020
Q1
$6.95M Buy
14,224
+4,224
+42% +$2.06M 1.41% 8
2019
Q4
$3.76M Buy
+10,000
New +$3.76M 0.46% 53
2018
Q4
Sell
-12,613
Closed -$5.1M 520
2018
Q3
$5.1M Buy
12,613
+4,509
+56% +$1.82M 0.6% 36
2018
Q2
$2.8M Buy
8,104
+4,256
+111% +$1.47M 0.35% 87
2018
Q1
$1.33M Buy
+3,848
New +$1.33M 0.17% 171
2017
Q1
Sell
-5,375
Closed -$1.97M 367
2016
Q4
$1.97M Hold
5,375
0.32% 83
2016
Q3
$2.16M Hold
5,375
0.35% 72
2016
Q2
$1.88M Buy
+5,375
New +$1.88M 0.31% 87
2015
Q4
Sell
-1,445
Closed -$672K 326
2015
Q3
$672K Hold
1,445
0.11% 190
2015
Q2
$737K Sell
1,445
-5,667
-80% -$2.89M 0.11% 197
2015
Q1
$3.21M Buy
7,112
+761
+12% +$344K 0.45% 66
2014
Q4
$2.61M Buy
6,351
+5,416
+579% +$2.22M 0.38% 69
2014
Q3
$337K Hold
935
0.05% 280
2014
Q2
$264K Sell
935
-260
-22% -$73.4K 0.04% 313
2014
Q1
$359K Sell
1,195
-489
-29% -$147K 0.05% 278
2013
Q4
$464K Buy
1,684
+136
+9% +$37.5K 0.07% 277
2013
Q3
$484K Sell
1,548
-56
-3% -$17.5K 0.07% 257
2013
Q2
$361K Buy
+1,604
New +$361K 0.06% 252